At the time of writing, Zepp Health Corporation ADR [ZEPP] stock is trading at $29.3, up 0.07%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZEPP shares have gain 21.88% over the last week, with a monthly amount drifted -30.24%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Zepp Health Corporation ADR fluctuated between $2.12 and $61.85. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Zepp Health Corporation ADR [NYSE: ZEPP] shares were valued at $29.3 at the most recent close of the market. An investor can expect a potential drop of -59.04% based on the average ZEPP price forecast.
Analyzing the ZEPP fundamentals
According to Zepp Health Corporation ADR [NYSE:ZEPP], the company’s sales were 233.37M for trailing twelve months, which represents an 78.72% jump. Gross Profit Margin for this corporation currently stands at 0.37% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.28 and Total Capital is -0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.63 points at the first support level, and at 27.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.87, and for the 2nd resistance point, it is at 30.44.
Ratios To Look Out For
It is important to note that Zepp Health Corporation ADR [NYSE:ZEPP] has a current ratio of 1.09. Further, the Quick Ratio stands at 0.78, while the Cash Ratio is 0.22. Considering the valuation of this stock, the price to sales ratio is 0.88, the price to book ratio is 1.86.
Transactions by insiders
Recent insider trading involved FAN Meihui, Director, that happened on Sep 29 ’25 when 3000.0 shares were purchased. Officer, Yeung Mike Yan completed a deal on Sep 04 ’25 to buy 44000.0 shares. Meanwhile, Affiliate Lai Jimmy Y. bought 1745.0 shares on Aug 27 ’25.
